Merck explores vaccine market in China; Elanco to distribute new pig vaccine in the EU; TVAX pulls in $2M to develop cancer drugs;

> Merck ($MRK) Animal Health and China Animal Husbandry Industry have established a partnership to explore animal vaccine opportunities in China. Release

> Prevtec Microbia has won European approval for its pig vaccine Coliprotec F4, which will be distributed in the EU by Eli Lilly's ($LLY) Elanco animal health unit. Release

> Kansas-based startup TVAX Animal Health, which is developing an immunotherapy-based cancer treatment for the veterinary market, raised an additional $2 million in funding, bringing its total financing to $12 million. Article

> France agricultural group InVivo pulled in €215 million ($235.3 million), led by private equity firm Eurazeo, and plans to use the funds to double the size of its animal health and nutrition division. Article

> Zoetis ($ZTS) awarded $974,000 in scholarships to 487 second- and third-year veterinary students in the U.S. and Caribbean. Release

> Denis Brinicombe Group in the U.K. has been named the first international licensee of Integrated Animal Health's dairy feed inclusion technology, Feed Mate, in a four-year deal. Release

> The FDA announced a new strategy for creating standards for animal food ingredients, which will include proposing rules for the use of additives. Release